A review of the epidemiological evidence on tea, flavonoids, and lung cancer

Journal of Nutrition

Volumn 138, Issue 8, 2008, Pages

  Arts, Ilja C W ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHIN; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE;

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONFERENCE PAPER; DIETARY INTAKE; HUMAN; LUNG CANCER; MEDLINE; OBSERVATIONAL STUDY; SMOKING; TEA;

CAMELLIA SINENSIS;

EID: 49449099395     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/138.8.1561s     Document Type: Conference Paper

References (60)

1. Higginson J. Etiological factors in gastrointestinal cancer in man. J Natl Cancer Inst. 1966;37:527-45.
2. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis. 2006;27:1301-9.
3. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis. 2006;27:1310-5.
4. Steevens J, Schouten LJ, Verhage BA, Goldbohm RA, van den Brandt PA. Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis. Br J Cancer. 2007;97:1291-4.
5. Balentine DA, Wiseman SA, Bouwens LCM. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr. 1997;37:693-704.
6. Arts ICW, Hollman PCH. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr. 2005;81:317S-25S.
7. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002;76:560-8.
8. Tabak C, Arts ICW, Smit HA, Heederik D, Kromhout D. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones. The MORGEN Study. Am J Respir Crit Care Med. 2001;164:61-4.
9. de Boer VCJ, Dihal AA, van der Woude H, Arts ICW, Wolffram S, Alink GM, Rietjens IMCM, Keijer J, Hollman PCH. Tissue distribution of quercetin in rats and pigs. J Nutr. 2005;135:1718-25.
10. Heilbrun LK, Nomura A, Stemmermann GN. Black tea consumption and cancer risk: a prospective study. Br J Cancer. 1986;54:677-83.
11. Huang C, Zhang X, Qiao Z, Guan L, Peng S, Liu J, Xie R, Zheng L. A case-control study of dietary factors in patients with lung cancer. Biomed Environ Sci. 1992;5:257-65.
12. Kinlen LJ, Willows AN, Goldblatt P, Yudkin J. Tea consumption and cancer. Br J Cancer. 1988;58:397-401.
13. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006;296:1255-65.
14. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutr Cancer. 1994;22:175-84.
15. Knekt P, Jarvinen R, Seppanen R, Hellovaara M, Teppo L, Pukkala E, Aromaa A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol. 1997;146:223-30.
16. Goldbohm RA, Hertog MGL, Brants HAM, Van Poppel G, Van den Brandt PA. Intake of flavonoids and cancer risk: a prospective cohort study. In: Amadò R, Andersson H, Bardosz S, Serra F, editors. Polyphenols in Food. Office for Official Publications of the European Communities, Luxembourg 1998: Proceeding of the 1st workshop of the COST 916 Action; 1997 Apr 16-9, Aberdeen, Scotland. EUR 18169 EN. p. 159-66.
17. Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P. Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control. 2001;12:789-96.
18. Arts ICW, Hollman PCH, Bueno de Mesquita HB, Feskens EJM, Kromhout D. Dietary catechins and epithelial cancer incidence: The Zutphen elderly study. Int J Cancer. 2001;92:298-302.
19. Arts ICW, Jacobs DR, Jr., Gross M, Harnack LJ, Folsom AR. Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control. 2002;13:373-82.
20. Wright ME, Mayne ST, Stolzenberg-Solomon RZ, Li Z, Pietinen P, Taylor PR, Virtamo J, Albanes D. Development of a comprehensive dietary antioxidant index and application to lung cancer risk in a cohort of male smokers. Am J Epidemiol. 2004;160:68-76.
21. Garcia-Closas R, Agudo A, Gonzalez CA, Riboli E. Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr Cancer. 1998;32:154-8.
22. De Stefani E, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Carzoglio JC, Ronco A, Olivera L. Dietary antioxidants and lung cancer risk: a case-control study in Uruguay. Nutr Cancer. 1999;34:100-10.
23. Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN. Intake of flavonoids and lung cancer. J Natl Cancer Inst. 2000;92:154-60.
24. Lagiou P, Samoli E, Lagiou A, Katsouyanni K, Peterson J, Dwyer J, Trichopoulos D. Flavonoid intake in relation to lung cancer risk: case-control study among women in Greece. Nutr Cancer. 2004;49:139-43.
25. Goldbohm RA, Hertog MG, Brants HA, van Poppel G, van den Brandt PA. Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst. 1996;88:93-100.
26. Zheng W, Doyle TJ, Kushi LH, Sellers TA, Hong CP, Folsom AR. Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol. 1996;144:175-82.
27. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors. 2000;13:49-54.
28. Nagano J, Kono S, Preston DL, Mabuchi K. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control. 2001;12:501-8.
29. Koo LC. Dietary habits and lung cancer risk among Chinese females in Hong Kong who never smoked. Nutr Cancer. 1988;11:155-72.
30. Mettlin C. Milk drinking, other beverage habits, and lung cancer risk. Int J Cancer. 1989;43:608-12.
31. Tewes FJ, Koo LC, Meisgen TJ, Rylander R. Lung cancer risk and mutagenicity of tea. Environ Res. 1990;52:23-33.
32. Ohno Y, Wakai K, Genka K, Ohmine K, Kawamura T, Tamakoshi A, Aoki R, Senda M, Hayashi Y, et al. Tea consumption and lung cancer risk: a case-control study in Okinawa, Japan. Jpn J Cancer Res. 1995;86:1027-34.
33. Axelsson G, Liljeqvist T, Andersson L, Bergman B, Rylander R. Dietary factors and lung cancer among men in west Sweden. Int J Epidemiol. 1996;25:32-9.
34. Mendilaharsu M, De Stefani E, Deneo-Pellegrini H, Carzoglio JC, Ronco A. Consumption of tea and coffee and the risk of lung cancer in cigarette-smoking men: a case-control study in Uruguay. Lung Cancer. 1998;19:101-7.
35. Zhong L, Goldberg MS, Gao YT, Hanley JA, Parent ME, Jin F. A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology. 2001;12:695-700.
36. Hu J, Mao Y, Dryer D, White K. Risk factors for lung cancer among Canadian women who have never smoked. Cancer Detect Prev. 2002;26:129-38.
37. Kubik AK, Zatloukal P, Tomasek L, Pauk N, Havel L, Krepela E, Petruzelka L. Dietary habits and lung cancer risk among non-smoking women. Eur J Cancer Prev. 2004;13:471-80.
38. Bonner MR, Rothman N, Mumford JL, He X, Shen M,Welch R, Yeager M, Chanock S, Caporaso N, Lan Q. Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lung cancer. Mutat Res. 2005;582:53-60.
39. Baker JA, McCann SE, Reid ME, Nowell S, Beehler GP, Moysich KB. Associations between black tea and coffee consumption and risk of lung cancer among current and former smokers. Nutr Cancer. 2005;52:15-21.
40. Kubik A, Zatloukal P, Tomasek L, Pauk N, Havel L, Dolezal J, Plesko I. Interactions between smoking and other exposures associated with lung cancer risk in women: diet and physical activity. Neoplasma. 2007;54:83-8.
41. Nagao M, Takahashi Y, Yamanaka H, Sugimura T. Mutagens in coffee and tea. Mutat Res. 1979;68:101-6.
42. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol. 2001;154:495-503.
43. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, et al. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alphatocopherol, beta-carotene cancer prevention study: effects of baseline characteristics and study compliance. J Natl Cancer Inst. 1996;88:1560-70.
44. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842-57.
45. Hakim IA, Hartz V, Harris RB, Balentine D, Weisgerber UM, Graver E, Whitacre R, Alberts D. Reproducibility and relative validity of a questionnaire to assess intake of black tea polyphenols in epidemiological studies. Cancer Epidemiol Biomarkers Prev. 2001;10:667-78.
46. Arts ICW, van de Putte B, Hollman PCH. Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. J Agric Food Chem. 2000;48:1752-7.
47. Hertog MGL, Hollman PCH, Van de Putte B. Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric Food Chem. 1993;41:1242-6.
48. Hertog MGL, Hollman PCH, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem. 1992;40:2379-83.
49. Arts ICW, van de Putte B, Hollman PCH. Catechin contents of foods commonly consumed in The Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J Agric Food Chem. 2000;48:1746-51.
50. USDA Database for the Flavonoid Content of Selected Foods. 2007. Release 2.1 [database on the Internet]. Beltsville, MD: U.S. Department of Agriculture. Available from: http://www.ars.usda.gov/Services/docs.htm?docid=6231.
51. Arab L, Blumberg JB. Introduction to the Proceedings of the Fourth International Scientific Symposium on Tea and Human Health. J Nutr. 2008;138:1526S-8S.
52. Henning SM, Choo JJ, Heber D. Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable. J Nutr. 2008;138:1529S-34S.
53. Auger C, Mullen W, Hara Y, Crozier A. Bioavailability of polyphenon E flavan-3-ols in humans with an ileostomy. J Nutr. 2008;138:1535S-42S.
54. Song WO, Chun OK. Tea is the major source of flavan-3-ol and flavonol in the U.S. diet. J Nutr. 2008;138:1543S-7S.
55. Kuriyama S. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr. 2008;138:1548S-53S.
56. Grassi D, Aggio A, Onori L, Croce G, Tiberti S, Ferri C, Ferri L, Desideri G. Tea, flavonoids, and NO-mediated vascular reactivity. J Nutr. 2008;138:1554S-60S.
57. Hakim IA, Chow HHS, Harris RB. Green tea consumption is associated with decreased DNA damage among GSTM1 positive smokers regardless of their hOGG1 genotype. J Nutr. 2008;138:1567S-71S.
58. Kelly SP, Gomez-Ramirez M, Montesi JL, Foxe JJ. L-Theanine and caffeine in combination affect human cognition as evidenced by oscillatory alpha-band activity and attention task performance. J Nutr. 2008;138:1572S-7S.
59. Mandel SA, Amit T, Kalfon L, Reznichenko L, Youdim MBH. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr. 2008;138:1578S-83S.
60. Stote KS, Baer DJ. Tea consumption may improve biomarkers of insulin sensitivity and risk factors for diabetes. J Nutr. 2008;138:1584S-8S.